Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$1.85B |
| 2 |
Marvell Technology
MRVL
|
+$1.57B |
| 3 |
Adobe
ADBE
|
+$1.52B |
| 4 |
Celanese
CE
|
+$1.08B |
| 5 |
Cenovus Energy
CVE
|
+$858M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.97B |
| 2 |
Broadcom
AVGO
|
+$1.4B |
| 3 |
D.R. Horton
DHI
|
+$1.26B |
| 4 |
Micron Technology
MU
|
+$1.24B |
| 5 |
GE Aerospace
GE
|
+$1.19B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.09% |
| 2 | Healthcare | 15.85% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Industrials | 11.99% |
| 5 | Communication Services | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VGR
276
DELISTED
Vector Group Ltd.
VGR
| $106M | 0.03% |
8,299,140
| – | – |
|
|
GDEN
277
DELISTED
Golden Entertainment
GDEN
| $105M | 0.03% |
2,511,071
+85,439
| +4% | +$3.58M |
|
278
PPG Industries
PPG
$25.6B
| $105M | 0.03% |
705,415
+388
| +0.1% | +$54.1K |
|
279
Semtech
SMTC
$12.9B
| $102M | 0.03% |
4,002,965
+3,686,252
| +1,164% | +$79.6M |
|
280
Willis Towers Watson
WTW
$30.9B
| $100M | 0.03% |
424,483
+220
| +0.1% | +$50.7K |
|
281
AT&T
T
$168B
| $98.6M | 0.03% |
6,182,702
+3,850,000
| +165% | +$65.6M |
|
282
Brookfield Infrastructure
BIPC
$4.96B
| $98.2M | 0.03% |
2,154,283
+113,265
| +6% | +$5.14M |
|
283
Atkore
ATKR
$3.18B
| $98M | 0.03% |
628,703
+162,548
| +35% | +$21.3M |
|
284
Novartis
NVS
$289B
| $91.1M | 0.02% |
903,243
+408
| +0% | +$40.8K |
|
285
Coupang
CPNG
$29B
| $91.1M | 0.02% |
5,236,880
+113,292
| +2% | +$1.85M |
|
286
PAR Technology
PAR
$744M
| $88.2M | 0.02% |
2,677,672
-300,000
| -10% | -$10M |
|
287
Infosys
INFY
$49.5B
| $88M | 0.02% |
5,474,119
+1,259
| +0% | +$19.7K |
|
288
MACOM Technology Solutions
MTSI
$24.3B
| $87.2M | 0.02% |
1,330,000
| – | – |
|
|
LTHM
289
DELISTED
Livent Corporation
LTHM
| $86.6M | 0.02% |
3,158,054
+934,573
| +42% | +$22.4M |
|
290
Fastenal
FAST
$58.9B
| $85.8M | 0.02% |
2,910,176
+1,074
| +0% | +$29.4K |
|
291
Denali Therapeutics
DNLI
$4.05B
| $83.7M | 0.02% |
2,837,652
+368,828
| +15% | +$10.4M |
|
|
PCH
292
DELISTED
PotlatchDeltic
PCH
| $83.3M | 0.02% |
1,576,968
| – | – |
|
293
Lumentum
LITE
$80.8B
| $82.4M | 0.02% |
1,452,774
+704,662
| +94% | +$35.2M |
|
|
CCC
294
CCC Intelligent Solutions
CCC
$4B
| $81.9M | 0.02% |
7,305,588
| – | – |
|
295
AstraZeneca
AZN
$245B
| $81.4M | 0.02% |
568,715
+50,988
| +10% | +$7.5M |
|
296
ICF International
ICFI
$1.57B
| $81.3M | 0.02% |
653,831
| – | – |
|
297
Fortive
FTV
$18.5B
| $81.1M | 0.02% |
1,439,795
| – | – |
|
|
GTLS
298
DELISTED
Chart Industries
GTLS
| $79.8M | 0.02% |
499,604
+497
| +0.1% | +$63.5K |
|
299
Essent Group
ESNT
$6.17B
| $79.6M | 0.02% |
1,700,000
| – | – |
|
300
New York Times
NYT
$10.3B
| $79.3M | 0.02% |
2,014,638
| – | – |
|
Similar funds
Capital Research Global Investors's Q2 2023 Portfolio in Review
As of Q2 2023, Capital Research Global Investors held 446 positions worth $373B, up 6.5% from $350B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital Research Global Investors's Q2 2023 filing shows 22 new, 206 increased, 135 reduced and 32 closed positions. Its largest new stake was Capital One: 7,999,882 shares worth $875M. The largest sale was Meta Platforms (Facebook), an estimated $1.97B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q2 2023 buy was Capital One: 7,999,882 shares worth $875M.
- Capital Research Global Investors added most to Texas Instruments in Q2 2023, an estimated $1.85B increase.
- Capital Research Global Investors's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.97B.
- Capital Research Global Investors fully exited Applied Materials in Q2 2023, selling an estimated $911M.
- Capital Research Global Investors's ten largest holdings make up 29% of its $373B portfolio in Q2 2023.
- Capital Research Global Investors opened 22 new positions and closed 32 in Q2 2023.
- Capital Research Global Investors's portfolio value rose 6.5% quarter-over-quarter to $373B.
Based on Capital Research Global Investors's 13F filing for Q2 2023, filed 11 Aug 2023.